🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Popularity Online

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several professionals said the demand for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the service has taken down problematic content and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, positive testimonials and step-by-step guides for mixing or injecting at home.

Within minutes of entering one group, a vendor posted contact information, where the majority of purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Item Information and Costs

Within these groups, messages show black plastic packages with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service said it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly significant health risks”.